Systematic Review of Stroke Post-COVID Vaccination
DOI:
https://doi.org/10.52783/jns.v14.3232Abstract
There are more than 245 million COVID-19 cases on record, and the WHO reports that approximately 5 million fatalities have been linked to the virus. Evidence of a possibility risk of stroke and other cerebrovascular issues swiftly followed the vascular and thromboembolic effects of COVID-19 that were first discovered during the epidemic. Since then, studies using comparative meta-analysis have been carried out to verify that SARS-CoV-2 infection raises the liability of ischemic stroke when compared to historical or current controls who are not infected. Apart from ischemic stroke, there have been indications of potential consequences such as hemorrhagic stroke and cerebral venous sinus thrombosis (CVST). SARS-CoV-2 vaccinations represent a major advance in the war against COVID-19. Companies and governments collaborated to develop several vaccines hostile to SARS-CoV-2 after a remarkable reaction to this worldwide disaster with destroying social, health, and economic effects. Within a year, these vaccines demonstrated noteworthy efficiency in randomized clinical studies that adapted into practical outcomes. Regretfully, following the introduction of the Ad26.COV2-S vaccine (Janssen) and the ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca), relatively few reports of thrombocytopenia and thromboembolic effects were made. This has led to a public vaccine hesitation. Nonetheless, the situation is quite complex since contamination with SARS-CoV-2 alone has a considerable hazard of thromboembolic consequences. This is particularly relevant to stroke and cerebrovascular accidents because cerebral thrombosis and hemorrhages carry a high risk of morbidity. The data about stroke and cerebrovascular problems associated with various COVID-19 vaccines is reviewed in the sections that follow. In doing so, we go over the many vaccination kinds, the physiological causes of stroke as a COVID-19 consequence, and neurological issues brought on by vaccination. In conclusion, we delineate the principal pathophysiologic anomalies and juxtapose the stroke risk associated with immunization
Downloads
References
Ndwandwe D, Wiysonge CS. COVID-19 Vaccines. Current Opinion in Immunology [Internet]. 2021 Jul;71:111–6. Available from: https://www.sciencedirect.com/science/article/pii/S095279152100090X
Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clinical Immunology [Internet]. 2020 Apr;215(1):108427. Available from:
https://www.sciencedirect.com/science/article/pii/S152166162030262X
Kakovan M, Shirkouhi SG, Zarei M, Andalib S. Stroke Associated with COVID-19 Vaccines. Journal of Stroke and Cerebrovascular Diseases. 2022 Mar;31(6):106440.
Available from: https://doi.org/10.1016/j.jstrokecerebrovasdis.2022.106440.
Biswas M, Sen S, Simmons J. Etiology and risk factors of ischemic stroke in Indian-American patients from a hospital-based registry in New Jersey, USA [Internet]. Carolina Digital Repository. 2009. Available from: https://cdr.lib.unc.edu/concern/articles/xd07h288v
Tan YK, Goh C, Leow AST, Tambyah PA, Ang A, Yap ES, et al. COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature. Journal of Thrombosis and Thrombolysis [Internet]. 2020 Jul 13;50(3):587–95. Available from: https://doi.org/10.1007/s11239-020-02228-y
Qi X, Keith KA, Huang JH. COVID-19 and stroke: A review. Brain Hemorrhages. 2020 Nov;2(2). Available from: https://doi.org/10.1016/j.hest.2020.11.001
Hess DC, Eldahshan W, Rutkowski E. COVID-19-Related stroke. Translational Stroke Research [Internet]. 2020 May 7;11(3):322–5. Available from: https://doi.org/10.1007/s12975-020-00818-9
Stamm B, Huang D, Royan R, Lee J, Marquez J, Desai M. Pathomechanisms and Treatment Implications for Stroke in COVID-19: A Review of the literature. Life [Internet]. 2022 Jan 29;12(2):207. Available from: https://www.mdpi.com/2075-1729/12/2/207
Kashte S, Gulbake A, El-Amin SF III, Gupta A. COVID-19 vaccines: rapid development, implications, challenges and future prospects. Human Cell [Internet]. 2021 Mar 7;34(3):711–33. Available from: https://doi.org/10.1007/s13577-021-00512-4
Khuroo MS, Khuroo M, Khuroo MS, Sofi AA, Khuroo NS. COVID-19 Vaccines: A Race Against Time in the Middle of Death and Devastation! Journal of Clinical and Experimental Hepatology. 2020 Jun; Available from: https://doi.org/10.1016/j.jceh.2020.06.003
Kaur SP, Gupta V. COVID-19 Vaccine: A comprehensive status report. Virus Research [Internet]. 2020 Oct 15;288:198114. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423510/
Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nature Communications [Internet]. 2020 Mar 27;11(1). Available from: https://www.nature.com/articles/s41467-020-15562-9
Divani AA, Andalib S, Di Napoli M, Lattanzi S, Hussain MS, Biller J, et al. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights. Journal of Stroke and Cerebrovascular Diseases [Internet]. 2020 Aug 1 [cited 2020 Sep 2];29(8):104941. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214348/
Al-Ramadan A, Rabab’h O, Shah J, Gharaibeh A. Acute and Post-Acute Neurological Complications of COVID-19. Neurology International [Internet]. 2021 Mar 9;13(1):102–19. Available from: https://www.mdpi.com/2035-8377/13/1/10
Geng X, Chandra A, Li W, Stone C, Ding Y. The cerebral circulation and cerebrovascular disease I: Anatomy. Brain Circulation [Internet]. 2017 Jan 1;3(2):45. Available from: https://journals.lww.com/brci/fulltext/2017/03020/the_cerebral_circulation_and_cerebrovascular.2.aspx
Morassi M, Bagatto D, Cobelli M, D’Agostini S, Gigli GL, Bnà C, et al. Stroke in patients with SARS-CoV-2 infection: case series. Journal of Neurology [Internet]. 2020 May 20;267(8):2185–92. Available from: https://doi.org/10.1007/s00415-020-09885-2
Acute encephalopathy associated with influenza and other viral infections [Internet]. PubMed. 2007. Available from: https://pubmed.ncbi.nlm.nih.gov/17784537/
Scullen T, Keen J, Mathkour M, Dumont AS, Kahn L. Coronavirus 2019 (COVID-19)–Associated Encephalopathies and Cerebrovascular Disease: The New Orleans Experience. World Neurosurgery [Internet]. 2020 May 28 [cited 2020 Jul 1]; Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255727/
Huang YH, Jiang D, Huang JT. SARS-CoV-2 Detected in Cerebrospinal Fluid by PCR in a Case of COVID-19 Encephalitis. Brain, Behavior, and Immunity. 2020 May;
Available from: https://doi.org/10.1016/j.bbi.2020.05.012
Subarachnoid hemorrhage [Internet]. PubMed. 2024. Available from: https://pubmed.ncbi.nlm.nih.gov/28722987/
Saiegh FA, Ghosh R, Leibold A, Avery MB, Schmidt RF, Theofanis T, et al. Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke. Journal of Neurology Neurosurgery & Psychiatry [Internet]. 2020 Apr 30;91(8):846–8. Available from: https://jnnp.bmj.com/content/91/8/846
Saiegh FA, Ghosh R, Leibold A, Avery MB, Schmidt RF, Theofanis T, et al. Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke. Journal of Neurology Neurosurgery & Psychiatry [Internet]. 2020 Apr 30;91(8):846–8. Available from: https://pubmed.ncbi.nlm.nih.gov/32354770/
Ahmad I, Rathore FA. Neurological manifestations and complications of COVID-19: A literature review. Journal of Clinical Neuroscience [Internet]. 2020 May 5;77:8–12. Available from: https://pubmed.ncbi.nlm.nih.gov/32409215/
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet [Internet]. 2020 Jan 24;395(10223):497–506. Available from: https://pubmed.ncbi.nlm.nih.gov/31986264/
Warlow C. Epidemiology of stroke. The Lancet [Internet]. 1998 Oct;352(S1-S4):S1–4. Available from: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(98)90086-1/fulltext
Andalib S, Lattanzi S, Di Napoli M, Petersen A, Biller J, Kulik T, et al. Blood pressure variability: a new predicting factor for clinical outcomes of intracerebral hemorrhage. Journal of Stroke and Cerebrovascular Diseases [Internet]. 2020 Oct 2;29(12):105340. Available from: https://pubmed.ncbi.nlm.nih.gov/33017754/
Marcucci R, Marietta M. Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines. Internal and Emergency Medicine [Internet]. 2021 Jun 30;16(5):1113–9. Available from: https://doi.org/10.1007/s11739-021-02793-x
Greinacher A, Langer F, Makris M, Pai M, Pavord S, Tran H, et al. Vaccine‐induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources. Journal of Thrombosis and Haemostasis [Internet]. 2021 Oct 25;20(1):149–56. Available from: https://pubmed.ncbi.nlm.nih.gov/34693641/
De Michele M, Kahan J, Berto I, Schiavo OG, Iacobucci M, Toni D, et al. Cerebrovascular complications of COVID-19 and COVID-19 vaccination. Circulation Research [Internet]. 2022 Apr 14;130(8):1187–203. Available from: https://doi.org/10.1161/circresaha.122.319954
Shen J, Hou Y, Zhou Y, Mehra R, Jehi L, Cheng F. The Epidemiological and Mechanistic Understanding of the Neurological Manifestations of COVID-19: A Comprehensive Meta-Analysis and A Network Medicine Observation. Frontiers in Neuroscience [Internet]. 2021 Feb 24;15. Available from: https://doi.org/10.3389/fnins.2021.606926
Annie F, Bates MC, Nanjundappa A, Bhatt DL, Alkhouli M. Prevalence and outcomes of acute ischemic stroke among patients ≤50 years of age with laboratory confirmed COVID-19 infection. The American Journal of Cardiology [Internet]. 2020 Jun 14;130:169–70. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7293843/
Ntaios G, Michel P, Georgiopoulos G, Guo Y, Li W, Xiong J, et al. Characteristics and outcomes in patients with COVID-19 and acute ischemic stroke. Stroke [Internet]. 2020 Jul 9;51(9). Available from: https://doi.org/10.1161/strokeaha.120.031208
Wolf PA, Kannel WB, McGee DL, Meeks SL, Bharucha NE, McNamara PM. Duration of atrial fibrillation and imminence of stroke: the Framingham study. Stroke [Internet]. 1983 Sep 1;14(5):664–7. Available from: https://doi.org/10.1161/01.str.14.5.664
Leasure AC, Khan YM, Iyer R, Elkind MSV, Sansing LH, Falcone GJ, et al. Intracerebral hemorrhage in patients with COVID-19. Stroke [Internet]. 2021 Jun 4;52(7). Available from: https://doi.org/10.1161/strokeaha.121.034215
Hippisley-Cox J, Patone M, Mei XW, Saatci D, Dixon S, Khunti K, et al. Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study. BMJ [Internet]. 2021 Aug 26;n1931. Available from: https://www.bmj.com/content/374/bmj.n1931
Thakur KT, Tamborska A, Wood GK, McNeill E, Roh D, Akpan IJ, et al. Clinical review of cerebral venous thrombosis in the context of COVID-19 vaccinations: Evaluation, management, and scientific questions. Journal of the Neurological Sciences [Internet]. 2021 Jun 5;427:117532. Available from: https://pubmed.ncbi.nlm.nih.gov/34134058/
Behnood Bikdeli, Chatterjee S, Arora S, Monréal M, Jiménez D, Krumholz HM, et al. Cerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19. Journal of the American College of Cardiology. 2021 Jul 1;78(4):408–11.Available from: https://doi.org/10.1016/j.jacc.2021.06.001
Liu Y, Shao Z, Wang H. SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia. Thrombosis Research [Internet]. 2021 Dec 6;209:75–9. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8647389/
Stam J. Thrombosis of the cerebral veins and sinuses. New England Journal of Medicine [Internet]. 2005 Apr 27;352(17):1791–8. Available from: https://doi.org/10.1056/nejmra042354
Krzywicka K, Heldner MR, Van Kammen MS, Van Haaps T, Hiltunen S, Silvis SM, et al. Post‐SARS‐CoV‐2‐vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency. European Journal of Neurology [Internet]. 2021 Jul 22;28(11):3656–62. Available from: https://doi.org/10.1111/ene.15029
Hwang J, Se Bee Lee, Lee S, Min Ho Lee, Koyanagi A, Jacob L, et al. Comparison of vaccine-induced thrombotic events between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines. Journal of Autoimmunity. 2021 Aug 1;122:102681–1. Available from: https://doi.org/10.1016/j.jaut.2021.102681
Pawlowski C, Rincón-Hekking J, Awasthi S, Pandey V, Lenehan P, Venkatakrishnan A, et al. Cerebral Venous Sinus Thrombosis is not Significantly Linked to COVID-19 Vaccines or Non-COVID Vaccines in a Large Multi-State Health System. Journal of Stroke and Cerebrovascular Diseases [Internet]. 2021 Jun 16;30(10):105923. Available from: https://pubmed.ncbi.nlm.nih.gov/34627592/
Nannoni S, De Groot R, Bell S, Markus HS. Stroke in COVID-19: A systematic review and meta-analysis. International Journal of Stroke [Internet]. 2020 Oct 26;16(2):137–49. Available from: https://doi.org/10.1177/1747493020972922
Ihle-Hansen H, Bøås H, Tapia G, Hagberg G, Ihle-Hansen H, Berild JD, et al. Stroke after SARS-COV-2 mRNA vaccine: A nationwide registry study. Stroke [Internet]. 2023 Mar 30;54(5). Available from: https://doi.org/10.1161/strokeaha.122.040430
Stefanou MI, Palaiodimou L, De Sousa DA, Theodorou A, Bakola E, Katsaros DE, et al. Acute arterial ischemic stroke following COVID-19 vaccination. Neurology [Internet]. 2022 Aug 24;99(14). Available from: https://doi.org/10.1212/wnl.0000000000200996
See I, Su JR, Lale A, Woo EJ, Guh AY, Shimabukuro TT, et al. US case reports of cerebral venous sinus thrombosis with thrombocytopenia after AD26.COV2.S vaccination, March 2 to April 21, 2021. JAMA [Internet]. 2021 Apr 30;325(24):2448. Available from: https://jamanetwork.com/journals/jama/fullarticle/2779731
Coronavirus Disease 2019 (COVID-19) Vaccine safety [Internet]. Vaccine Safety. 2024.
Oliver SE, Wallace M, See I, Mbaeyi S, Godfrey M, Hadler SC, et al. Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021. MMWR Morbidity and Mortality Weekly Report [Internet]. 2022 Jan 20;71(3):90–5. Available from: https://www.cdc.gov/mmwr/volumes/71/wr/mm7103a4.htm?s_cid=mm7103a4_w
Stefanou MI, Palaiodimou L, De Sousa DA, Theodorou A, Bakola E, Katsaros DE, et al. Acute arterial ischemic stroke following COVID-19 vaccination. Neurology [Internet]. 2022 Aug 24;99(14). Available from: https://doi.org/10.1212/wnl.0000000000200996
Burn E, Li X, Delmestri A, Jones N, Duarte-Salles T, Reyes C, et al. Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in the United Kingdom. Nature Communications [Internet]. 2022 Nov 23;13(1). Available from: https://www.nature.com/articles/s41467-022-34668-wa
Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nature Medicine [Internet]. 2022 Feb 7;28(3):583–90. Available from: https://www.nature.com/articles/s41591-022-01689-3
People with Certain Medical Conditions and COVID-19 Risk Factors [Internet]. COVID-19. 2024. Available from: https://www.cdc.gov/covid/risk-factors/?CDC_AAref_Val=https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html
Causes and risk factors | NHLBI, NIH [Internet]. NHLBI, NIH. 2023. Available from: https://www.nhlbi.nih.gov/health/stroke/causes
Sadoff J, Gray G, Vandebosch A, Cárdenas V, Shukarev G, Grinsztejn B, et al. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. New England Journal of Medicine [Internet]. 2021 Apr 21;384(23):2187–201. Available from: https://doi.org/10.1056/nejmoa2101544
News-Medical. SARS-CoV-2 infection and Ad26.COV2.S vaccination may increase risk of stroke post-vaccination [Internet]. News-Medical. 2024. Available from: https://www.news-medical.net/news/20230213/SARS-CoV-2-infection-and-Ad26COV2S-vaccination-may-increase-risk-of-stroke-post-vaccination.aspx
Lamb YN. BNT162b2 mRNA COVID-19 vaccine: First approval. Drugs [Internet]. 2021 Mar 1;81(4):495–501. Available from: https://doi.org/10.1007/s40265-021-01480-7
Dias L, Soares-Dos-Reis R, Meira J, Ferrão D, Soares PR, Pastor A, et al. Cerebral Venous Thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine. Journal of Stroke and Cerebrovascular Diseases [Internet]. 2021 May 25;30(8):105906. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8148614/
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
